Small study measures antifungal levels in septic shock patients
NCT ID NCT02805049
First seen Nov 21, 2025 · Last updated May 10, 2026 · Updated 19 times
Summary
This study looked at how the body processes antifungal drugs (echinocandins) in 24 adults with septic shock caused by a serious abdominal infection (peritonitis). The goal was to measure drug levels in the blood to help doctors give the right dose. It did not test a new treatment, but aimed to improve understanding of drug behavior in critically ill patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, 30029, France
-
Royal Brisbane Women's Hospital
Herston, 4029, Australia
Conditions
Explore the condition pages connected to this study.